BMCS New Approaches to the treatments of Neurodegenerative Diseases
Event
New approaches to Neurodegenerative Diseases
Date
Monday 5th – Tuesday 6th April, 2027
Place
Wellcome Genome Campus, Hinxton, Saffron Walden CB10 1RQ
Downloads and Links
Submit your abstract here.
Synopsis
A recent study estimated that 3.4 billion people worldwide are effected by neurodegenerative diseases[1] placing a major burden on health systems. For many diseases the current treatments only address the symptoms and are not disease progression, whilst these treatments can be very helpful there is an urgent need for disease modifying therapies. Over the last few years we have seen significant advances in our understanding of the underlying biology, identification of new therapeutic targets and the design of novel drug candidates. This meeting will highlight leading edge research in the design and development of new therapeutics.
This meeting is building upon the very successful New Approaches to the Treatment in Parkinson’s meeting held in November 2025.
Want to become an RSC member?
To join the RSC in order to qualify for discounted registration fees at all RSC events, please follow this RSC link
Call for Abstracts
Abstract submission is now open, to submit your abstract click here.
The deadline for oral abstract submission is Midnight (GMT), Monday 14th December, 2026.
The deadline for poster abstract submission is Midnight (GMT), Monday 1st February, 2027.
Registration
Registration will open soon.
Sponsorship/Exhibition Opportunities
Sponsorship/Exhibition Opportunities will open soon.
To register your interest, please contact events@hg3.co.uk
Organising Committee
Nadia Ahmad, Eli Lilly
Sophie Nyberg, MND
Elizabeth Railly, MND
Tim Rooney, University of Cambridge
John Skidmore, University of Cambridge
Chris Swain, Cambridge MedChem Consulting
Iwona Ziomkiewicz, Parkinson’s UK
Secretariat Contact and Further Information
Hg3 Conferences Ltd
+44 (0)1423 529333
E-mail